MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. scores highest on Earnings (55) and lowest on Price (20). Its PosiPenta is 40.02 out of 100, around the middle of similar companies.
On the Penta Grid this week, MIRA Pharmaceuticals, Inc. is Grid #540 of 837 in the Healthcare sector in United States, and Grid #2,885 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| MIRA Pharmaceuticals, Inc. | 40.02 | 20 | 55 | 27 | 51 | 46 |
| DocGo Inc. | 39.62 | 49 | 57 | 19 | 33 | 40 |
| Atossa Therapeutics, Inc. | 37.28 | 38 | 28 | 27 | 60 | 34 |
| IGC Pharma, Inc. | 38.85 | 16 | 46 | 39 | 39 | 55 |
| PetMed Express, Inc. | 44.68 | 38 | 59 | 21 | 52 | 52 |
| ABVC BioPharma, Inc. | 38.47 | 25 | 40 | 31 | 39 | 57 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.55 |
| P/B ratio | 3.26 |
EEarnings
| Trailing EPS | ₹-107.97 |
| Forward EPS | ₹-38.83 |
NNitro
| Price | 59.89 |
| 52-week high | 173.33 |
| 52-week low | 56.83 |
| Fall from 52-week high | 65.4% |
TTorque
| Return on equity (ROE) | -217.12% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.49 |
| Market cap | ₹251 Cr |
| Insider holding | 30.58% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is MIRA Pharmaceuticals, Inc.'s PosiPenta score?
MIRA Pharmaceuticals, Inc.'s PosiPenta is 40.02 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does MIRA Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, MIRA Pharmaceuticals, Inc. is Grid #540 of 837 in the Healthcare sector in United States, and Grid #2,885 of 4,000 in United States.
Which PosiPenta pillar is strongest for MIRA Pharmaceuticals, Inc.?
Earnings (growth), with a score of 55 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for MIRA Pharmaceuticals, Inc.?
Price (valuation), with a score of 20 out of 100: weaker than most similar companies.
Has MIRA Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 4.05 points, from 35.97 to 40.02.
PositoAI is for research and education only and is not investment advice.